Toolgen transfers CRISPR-Cas9 gene editing technology to AvinoGen.

게시됨 2025년 11월 11일

Tridge 요약

[Agricultural, Fisheries and Livestock Newspaper=Reporter Kim Jin-oh] Gene editing technology company ToolGen (CEO Yoo Jong-sang) announced on the 6th that it has signed a "CRISPR-Cas9 gene editing technology transfer agreement" with avian bioengineering company AvinoGen (CEO Han Jae-yong). ToolGen is the only company in Korea to hold the source patent for CRISPR-Cas9 gene editing. It has secured a total of 30 related patents in 10 major countries, including the United States, Europe, and Japan, and based on these, has concluded more than 20 technology transfer agreements with global companies such as Monsanto and Thermo Fisher, leading the commercialization of the technology. AvinoGen was founded in 2022 by Professor Han Jae-yong from the Department of Animal Biotechnology at Seoul National University.

원본 콘텐츠

Application to algae germ cell correction platform...Accelerating next-generation bio research Gene correction technology company Toolgen (CEO Yoo Jong-sang) announced on the 6th that it has signed a "CRISPR-Cas9 gene correction technology transfer agreement" with algae bioengineering company AvinoGen (CEO Han Jae-yong). Toolgen is the only company in Korea to hold the source patent for CRISPR-Cas9 gene correction. It has secured a total of 30 related patents in 10 major countries including the United States, Europe, and Japan, and based on these, it has concluded more than 20 technology transfer agreements with global companies such as Monsanto and Thermo Fisher, leading the commercialization of the technology. AvinoGen is a bio company established by Professor Han Jae-yong from Seoul National University's Department of Animal Biotechnology as an on-campus venture in 2022. Since its establishment, AvinoGen has been developing its business centered around algae germ cell gene ...

출처: Aflnews